Home » Topics » Regulatory » Patents

Patents
RSS

Shanghai Hongheng Biomedical Technology divulges anticancer compounds

April 12, 2022

UCL Business synthesizes new TTR stabilizers

April 11, 2022

Merck & Co. divulges new ceramide glucosyltransferase inhibitors

April 11, 2022

New Bruton tyrosine kinase inhibitors synthesized at Hutchison MediPharma

April 11, 2022

Macrophage colony-stimulating factor 1 receptor inhibitors identified at Hutchison MediPharma

April 11, 2022

Johns Hopkins University, the Lieber Institute describe new RNA polymerase inhibitors

April 11, 2022

BioWorld MedTech Patent Highlights: Week 13

From Current Patent Gazette

April 8, 2022

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

Soltego discloses new SIK inhibitors

April 8, 2022

Medshine Discovery patents AKR1C3 inhibitors

April 8, 2022

Cadila Healthcare discloses new ACP1 inhibitors

April 8, 2022

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...